News

In President Joe Biden’s first 100 days, the S&P 500 surged more than 9%. Under Trump, it’s tanked almost 8%.

Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported first-quarter sales—especially those of its key Eylea eye disease drug—that missed analysts' estimates by a wide margin.

CEOs are tightening their belts because of the current market uncertainty, Solomon said.

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo Nordisk to bring weight-loss drug Wegovy to its customers.

Job openings decreased in March, and as employers react to April's tariffs, further pullbacks are likely in the months ahead.

Heading into Meta's Q1 earnings, analysts are watching for key updates on AI initiatives, Instagram Reels, and growth in ad spending.

(Reuters) -The dramatic shift in U.S. domestic and foreign policy since President Donald Trump returned to the White House on January 20 has sent shockwaves across global financial markets. Trump's multi-front trade war and constant flip-flops on tariffs have upended supply chains, clouded business outlooks and stoked fears of a recession in the U.S. The S&P 500 has lost nearly 8% since his January 20 inauguration. Data analytics provider Palantir, which works with the Department of Homeland Security, has surged nearly 60% since Trump came into power as the Department of Defense prioritizes a new software acquisition effort to enhance the U.S. military.